載入...
Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
BACKGROUND: There is evidence supporting the use of ketamine in treatment-resistant depression (TRD). However, there are some safety and tolerability concerns associated with ketamine. This study aimed to investigate ketamine’s safety and tolerability to the central nervous system and to assess the...
Na minha lista:
| 發表在: | Ther Adv Psychopharmacol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138297/ https://ncbi.nlm.nih.gov/pubmed/34046159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20451253211011021 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|